公司概覽
業務類別 --
業務概覽 Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consultingservices for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.
公司地址 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131
電話號碼 +86 2150461111
傳真號碼 +86 2150461000
公司網頁 https://www.wuxiapptec.com
員工數量 39414
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Zhaohui Zhang Director, Vice President and Chief Operating Officer, China -- 18/03/2025
Mr. Edward Hu Vice Chairman of the Board and Global Chief Investment Officer -- 18/03/2025
Dr. Steve Qing Yang, PhD Director and Co-Chief Executive Officer -- 18/03/2025
Dr. Ge Li Chairman of the Board, Chief Executive Officer and President -- 18/03/2025
Dr. Minzhang Chen Director and Co-Chief Executive Officer -- 18/03/2025
 
董事會成員
董事會 職務 更新日期
Ms. Lu-Wong Christine Shaohua Independent Director 18/03/2025
Mr. Xuesong Jeff Leng Independent Director 18/03/2025
Mr. Zhaohui Zhang Director, Vice President and Chief Operating Officer, China 18/03/2025
Mr. Edward Hu Vice Chairman of the Board and Global Chief Investment Officer 18/03/2025
Mr. Zhang Xin Independent Director 18/03/2025
Dr. Steve Qing Yang, PhD Director and Co-Chief Executive Officer 18/03/2025
Dr. Yibing Wu, PhD Director 18/03/2025
Dr. Ge Li Chairman of the Board, Chief Executive Officer and President 18/03/2025
Mr. Xiaomeng Tong Director 18/03/2025
Dr. Minzhang Chen Director and Co-Chief Executive Officer 18/03/2025
Ms. Zhiling Zhan Independent Director 18/03/2025
Mr. Yu Wei Independent Director 18/03/2025
 
所屬ETF (更新日期: 07/03/2026 03:43)
代號 名稱 佔比% 持有日期
FXIiShares China Large-Cap ETF0.08%28/02/2026
MCHIiShares MSCI China ETF0.03%28/02/2026
EEMiShares MSCI Emerging Markets ETF0.03%27/02/2026
VEUVanguard FTSE All-Wld ex-US ETF0.03%31/01/2026
AVEMAvantis Emerging Markets Equity ETF0.02%28/02/2026
SCHESchwab Emerging Markets Equity ETF™0.02%28/02/2026
IXUSiShares Core MSCI Total Intl Stk ETF0.02%28/02/2026
SPEMState Street® SPDR® Portfolio EM ETF0.01%27/02/2026
VTVanguard Total World Stock ETF0.01%31/01/2026
DFAEDimensional Emerging Core Equity Mkt ETF0.01%27/02/2026
DFEMDimensional Emerging Markets Cr Eq 2 ETF0.01%27/02/2026
DFAXDimensional World ex US Core Eq 2 ETF0.01%27/02/2026
AAXJiShares MSCI All Country Asia ex Jpn ETF0.01%28/02/2026
ACWIiShares MSCI ACWI ETF0.004%28/02/2026
CXSEWisdomTree China ex-State-Owd Entpr ETF0.004%27/02/2026
KUREKraneShares MSCI All China Hlth Care ETF0.003%27/02/2026
ACWXiShares MSCI ACWI ex US ETF0.003%28/02/2026
VSGXVanguard ESG International Stock ETF0.003%31/01/2026
EEMAiShares MSCI Emerging Markets Asia ETF0.003%28/02/2026
UEVMVictoryShares Emerging Mkts Val MomtETF0.002%27/02/2026
 1    2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.